Cost utility analysis of fixed-dose and free-dose combinations of oral medications in type 2 diabetes patients-Reference-Cited by-同舟云学术

Cost utility analysis of fixed-dose and free-dose combinations of oral medications in type 2 diabetes patients

Published:2016-05-26 Issue:3 Volume:7 Page:181-187
ISSN:1759-8885
Container-title:Journal of Pharmaceutical Health Services Research
language:en
Short-container-title:J Pharm Health Serv Res

Author:

Vaidya Varun¹,Anupindi Vamshi Ruthwik²,Pinto Sharrel¹,Kaun Megan³

Affiliation:

1. Health Outcomes and Socioeconomic Sciences; College of Pharmacy and Pharmaceutical Sciences; University of Toledo; Toledo OH USA

2. Health Economics and Outcomes Research; Mu Sigma Inc.; Princeton NJ USA

3. Pharmacy Practice; College of Pharmacy and Pharmaceutical Sciences; University of Toledo; Toledo OH USA

Publisher

Oxford University Press (OUP)

Subject

Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jphs.12139/fullpdf

Reference31 articles.

1. Standards of medical care in diabetes - 2015;American Diabetes Association;Diabetes Care,2015

2. WHO Press Global Status Report on Noncommunicable Diseases 2010 Geneva 27, Switzerland World Health Organization

3. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group;J Pediatr,1994

4. National Center for Health Statistics Centers for Disease Control and Prevention, 2004-2006 National Health Interview Survey (NHIS) http://www.cdc.gov/nchs/nhis.htm

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluation of Fixed-dose Drug Combinations: A Systematic Review;2024-06-06

2. A survey on consciousness towards the proper use of metformin and medical cost in Japanese patients with type 2 diabetes;Journal of Clinical Biochemistry and Nutrition;2021

3. Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II;Health Services Insights;2020-01

4. Cost-utility analysis of methylphenidate and amphetamine/dexamphetamine in adults with attention-deficit hyperactivity disorder;Journal of Pharmaceutical Health Services Research;2017-03-05